Season 2 · Episode 6
Putting Quality Over Quantity with Radioligand Therapy
The Good News About Cancer · Charles Ryan MD, Alicia Morgans MD MPH
March 17, 202623m 48s
Audio is streamed directly from the publisher (episodes.captivate.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Radioligand therapy is a form of precise cancer treatment that targets specific cells with a radioactive substance. It’s used to treat prostate cancer and some types of neuroendocrine cancer, delivering powerful results with minimal impact on patient quality of life. Dr. Michael Morris helped develop radioligands for prostate cancer, and he tells Chuck and Alicia about the huge promise he sees in these treatments going forward.